Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ultragenyx Pharmaceutical Inc. buy William Blair

Start price
€31.00
28.05.25 / 50%
Target price
€57.43
28.05.26
Performance (%)
-36.15%
End price
€19.80
29.05.26
Summary
This prediction ended on 29.05.26 with a price of €19.80. Massive losses of -36.15% were the result for the BUY prediction by William_Blair. William_Blair has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ultragenyx Pharmaceutical Inc. -1.818% -1.818% -36.772%
iShares Core DAX® -1,86 % 0,67 % 0,92 %
iShares Nasdaq 100 -3,32 % 4,99 % 33,72 %
iShares Nikkei 225® -2,30 % 6,13 % 52,96 %
iShares S&P 500 -1,31 % 3,40 % 24,67 %

Comments by William_Blair for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -36.15%
Target price 57.434
Change
Ends at 28.05.26

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is now covered by analysts at William Blair. They set an "outperform" rating and a $65.00 price target on the stock.
Ratings data for RARE provided by MarketBeat

In the thread Trading Ultragenyx Pharmaceutical Inc.
Prediction Buy
Perf. (%) -36.15%
Target price 57.434
Change
Ends at 28.05.26

Die von William_Blair gewählte maximale Laufzeit wurde überschritten